{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:57:44Z","timestamp":1785326264911,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.semarthrit.2014.10.004","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T05:45:17Z","timestamp":1414043117000},"page":"518-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature"],"prefix":"10.1016","volume":"44","author":[{"given":"Dilia","family":"Giuggioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreina","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lumetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clodoveo","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2014.10.004_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevic","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000206699","article-title":"Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up","volume":"70","author":"Invernizzi","year":"1983","journal-title":"Acta Haematol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib5","first-page":"115","article-title":"Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease","volume":"88","author":"Monti","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinemia","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia cryoglobulinemia: demographic, clinical, and serological features, and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib8","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1365-2362.2001.00824.x","article-title":"The cryoglobulins: an overview","volume":"31","author":"Dammacco","year":"2001","journal-title":"Eur J Clin Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.semarthrit.2014.10.004_bib9","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1590-8658(07)80005-3","article-title":"HCV-related autoimmune and neoplastic disorders: the HCV sindrome","volume":"39","author":"Ferri","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2011.07.005","article-title":"Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature","volume":"11","author":"Ferri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar3865","article-title":"Current treatment of hepatitis C-associated rheumatic diseases","volume":"14","author":"Ferri","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1 Suppl. 57","key":"10.1016\/j.semarthrit.2014.10.004_bib13","first-page":"84","article-title":"Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia","volume":"28","author":"Quartuccio","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2007.081653","article-title":"Rituximab combined with Peg-Interferon-Ribavirin in refractory HCV-associated cryoglobulinemia vasculitis","volume":"67","author":"Saadoun","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/ard.2011.150755","article-title":"Preliminary classification criteria for the cryoglobulinaemic vasculitis","volume":"70","author":"De Vita","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib18","series-title":"Position document: hard-to-heal wounds: a holistic approach","author":"European Wound Management Association (EWMA)","year":"2008"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib19","series-title":"Principles of best practice. Wound exudate and the role of dressings. A consensus document","author":"World Union of Wound Healing Societies (WUWHS)","year":"2007"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib20","series-title":"Principles of best practice: minimising pain at wound dressing-related procedures. A consensus document","author":"World Union of Wound Healing Societies (WUWHS)","year":"2004"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1051\/ject\/201042020","article-title":"Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer","volume":"42","author":"Akingboye","year":"2010","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib22","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00296-011-2038-0","article-title":"Platelet gel in the treatment of severe scleroderma skin ulcers","volume":"32","author":"Giuggioli","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1098\/rsif.2009.0403","article-title":"A review of tissue-engineered skin bioconstructs available for skin reconstruction","volume":"7","author":"Shevchenko","year":"2010","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.autrev.2013.06.013","article-title":"Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature","volume":"12","author":"Giuggioli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/SPC.0b013e32835d7ed2","article-title":"Evidence-based approach to manage persistent wound-related pain","volume":"7","author":"Woo","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib26","unstructured":"Moffatt CJ, Franks PJ, Hollinworth H. Understanding wound pain and trauma: an international perspective. EWMA Position Document: pain at wound dressing changes 2002."},{"key":"10.1016\/j.semarthrit.2014.10.004_bib27","series-title":"Wound Care Society educational leaflet","article-title":"Pain and wound care","author":"Hollinworth","year":"2000"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.12968\/jowc.2001.10.1.26042","article-title":"Using a topical anaesthetic cream to reduce pain during sharp debridement of chronic leg ulcers","volume":"10","author":"Rosenthal","year":"2001","journal-title":"J Wound Care"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib29","article-title":"Procedural pain management in the treatment of scleroderma digital ulcers","author":"Giuggioli","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"1 Pt 1","key":"10.1016\/j.semarthrit.2014.10.004_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0190-9622(91)70168-2","article-title":"Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients","volume":"25","author":"Cohen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib31","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/rheumatology\/ken303","article-title":"Influence of inherited and acquired thrombophilic defects on the clinical manifestations of mixed cryoglobulinaemia","volume":"47","author":"Casato","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3899\/jrheum.090790","article-title":"Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy","volume":"37","author":"Landau","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/ard.58.11.698","article-title":"Prevalence and clinical features of cryoglobulinaemia in multitransfused beta-thalassaemia patients","volume":"58","author":"Perniola","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3899\/jrheum.100898","article-title":"Clinical spectrum, treatment, and outcome of patients with type II mixed cryoglobulinemia without evidence of hepatitis C infection","volume":"38","author":"Foessel","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jmii.2011.12.027","article-title":"Comparison of cryoglobulinemia in children and adults","volume":"46","author":"Liou","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/rheumatology\/41.3.290","article-title":"Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia","volume":"41","author":"Rieu","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archderm.139.3.391","article-title":"Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment","volume":"139","author":"Auzerie","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib38","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib39","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib40","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1590-8658(07)80024-7","article-title":"Rituximab in mixed cryoglobulinemia: increased experience and perspectives","volume":"39","author":"De Vita","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2007.06.008","article-title":"Efficacy of low-dose rituximab for mixed cryoglobulinemia","volume":"125","author":"Visentini","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-007-8019-0","article-title":"Rituximab as a therapeutic tool in severe mixed cryoglobulinemia","volume":"34","author":"Roccatello","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.autrev.2011.04.033","article-title":"A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection","volume":"10","author":"Visentini","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib46","first-page":"499","article-title":"Disorders of blood: IV. Cryoglobulinemia: a preliminary report","volume":"55","author":"Buteler","year":"1963","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib47","first-page":"1287","article-title":"A propos de trois nouvelles observations de gangrene d\u05f3origine veineuse dont l\u05f3une certainement en rapport avec une cryoglobulinemie","volume":"24","author":"Fontaine","year":"1970","journal-title":"Ann Chir"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00006534-197011000-00021","article-title":"Skin necrosis secondary to cryoglobulinemia. Case report","volume":"46","author":"Riu","year":"1970","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib49","first-page":"323","article-title":"Very extensive ulcers in a case of mixed cryoglobulinemia","volume":"31","author":"Goldschmidt-Clermont","year":"1978","journal-title":"Phlebologie"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/art.1780240902","article-title":"The effect of combination therapy (steroids, immunosuppressives, and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic, and vascular involvement","volume":"24","author":"Geltner","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0272-6386(84)80031-1","article-title":"Plasmapheresis as sole therapy in a patient with essential mixed cryoglobulinemia","volume":"4","author":"Delaney","year":"1984","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/003693308803300413","article-title":"Essential mixed cryoglobulinaemia presenting with chronic perianal skin ulceration","volume":"33","author":"Ralston","year":"1988","journal-title":"Scott Med J"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib53","first-page":"135","article-title":"Cryoglobulinemia: a case report","volume":"2","author":"Sundar","year":"1994","journal-title":"J Indian Rheum Assoc"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib54","article-title":"Use of interferon-2 alpha in the treatment of cryoglobulinaemic leg ulcers","volume":"17","author":"Cheung","year":"1995","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archderm.1996.03890290024003","article-title":"Treatment of recalcitrant leg ulcers in cryoglobulinemia types I and II with plasmapheresis","volume":"132","author":"Mcgovern","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archderm.1997.03890390133025","article-title":"Failure of plasmapheresis in the treatment of recalcitrant skin ulcers in a patient with mixed cryoglobulinemia","volume":"133","author":"Machet","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2169\/internalmedicine.36.62","article-title":"Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms","volume":"36","author":"Konishi","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib58","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/1529-0131(199805)41:5<868::AID-ART14>3.0.CO;2-7","article-title":"Clinical image: cutaneous ulceration in type II cryoglobulinemia","volume":"41","author":"Wisnieski","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib59","first-page":"1007","article-title":"Peri-lesional injections of granulocytemacrophage colony-stimulating factor in the management of chronic leg ulcers in type II mixed cryoglobulinemia","volume":"85","author":"Cavanna","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib60","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/00006534-200104150-00020","article-title":"Necrotizing cutaneus cryoglobulinemic vasculopathy","volume":"107","author":"Mahabir","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib61","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1053\/j.ajkd.2003.12.057","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure","volume":"43","author":"Ghijsels","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.20207","article-title":"Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstrom macroglobulinemia does not indicate failure of response","volume":"77","author":"Ghobrial","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib63","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/000331970505600418","article-title":"Type III Mixed cryoglobulinemia associated with digital necrotic ulcer successfully treated with intermittent intravenous pulse cyclophosphamide: a case report","volume":"56","author":"Cakir","year":"2005","journal-title":"Angiology"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0001-7310(06)73364-6","article-title":"Cryoglobulinemic syndrome: presentation of four cases with skin involvement","volume":"97","author":"Su\u00e1rez-Amor","year":"2006","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib65","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s10067-006-0295-1","article-title":"Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers","volume":"26","author":"Hamaguchi","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D36M82N0J1","article-title":"Hepatitis C virus infection, type III cryoglobulinemia, and necrotizing vasculitis","volume":"13","author":"Brownell","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib67","first-page":"91","article-title":"Cryoglobulinemic vasculitis with multiple digital necrosis in viral hepatitis","volume":"46","author":"Mironiuc","year":"2008","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib68","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00296-007-0462-y","article-title":"Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab","volume":"28","author":"Braun","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib69","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.4076\/1757-1626-2-7859","article-title":"Successful combination of Rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case report","volume":"2","author":"Tallarita","year":"2009","journal-title":"Cases J"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1534734609344126","article-title":"Case presentation: xenograft resistance to protease degradation in a vasculitic ulcer","volume":"8","author":"Mulder","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib71","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11845-008-0203-6","article-title":"Acute type II cryoglobulinaemic vasculitis mimicking atherosclerotic peripheral vascular disease","volume":"179","author":"Saeed","year":"2010","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib72","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00296-009-1106-1","article-title":"Long-term efficacy of rituximab in hepatitis C virus-associated cryoglobulinemia","volume":"30","author":"Da Silva Fucuta Pereira","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib73","first-page":"298","article-title":"Mixed cryoglobulinemia","volume":"36","author":"Roque","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib74","first-page":"64","article-title":"Successful rituximab therapy of HCV-cryoglobulinemic vasculitis with severe ulcerative and necrotic lesions of the skin","volume":"90","author":"Ignatova","year":"2012","journal-title":"Klin Med (Mosk)"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2110-5820-2-31","article-title":"Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis","volume":"2","author":"Zaidan","year":"2012","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib76","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1756-185X.12114","article-title":"Flare of essential mixed cryoglobulinemic vasculitis with hemorrhagic bullous purpura after rituximab infusion","volume":"16","author":"Zenone","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2169\/internalmedicine.53.1203","article-title":"Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier","volume":"53","author":"Yamazaki","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2014.10.004_bib78","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.bjps.2014.03.033","article-title":"Reconstruction of soft tissue necrosis secondary to cryoglobulinaemia","volume":"67","author":"Harish","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:29:39Z","timestamp":1717489779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017214002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0049017214002455"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}